NewsBite

IPO

December 2025

What will it take to fire up a sluggish ASX listings market in 2026?

The pipeline for initial public offerings looks healthy going into the new year, but fund managers warn the prospect of higher interest rates poses a big risk.

JP Morgan head of equity capital markets Justin Grimmond.

The challenges and upside tipped for equity capital markets in 2026

Bankers and investors see a robust pipeline for IPOs in 2026, but will fund managers warm to floats after a disappointing performance from the recent crop?

Amid global IPO gloom, the HKEX shines like a beacon of activity, with a flurry of last-minute listings in December capping a standout year.

How Hong Kong became the standout IPO market in 2025

Equity exchanges are drying up as companies tap deepening pools of private capital, consolidate, delist or rationalise dual listings. HKEX is one exception.

KTEK System’s hardware is used by defence manufacturers across the US, Europe and Israel.

Regal Fund backs drone parts manufacturer’s pre-IPO raising

KTEK Systems is a supplier of airframes for combat drones to defence manufacturers in the US, European Union and Israel.

Tectonic Investment Management chief investment officer Benjamin Haan.

Meet the small Northern Rivers fund with 7pc of Firmus

Tectonic, a vehicle started by a trio of former Partners Group operatives, is an earlier backer of the runaway artificial intelligence infrastructure start-up.

Advertisement
There were 10 IPOs worth $100 million or more on the ASX this year.

Dud deals, dud timing: Late IPO flops spoil a momentum-building year

The three most recent floats to raise $100 million or more to list have performed terribly, tarnishing a mid-year resurgence.

According to Dealogic, just 15 businesses this year joined the London Stock Exchange’s three trading markets via IPOs.

London’s stock exchange struggles for relevance as IPOs dry up

Stock markets around the world are drying up as companies tap widening and deepening pools of private capital, consolidate, delist or rationalise dual listings.

Sharon AI founder Andrew Leece. The company’s plan is to rent out computing muscle to companies across Asia.

Sharon AI pre-IPO raising upsized; seeks $2b debt

Allocation emails have gone out to bidders saying the deal is done and has been upsized to $150 million following strong demand.

The Whiskey Project has won a US defence contract.

Ellerston-backed defence play charts course for the ASX; banks appointed

The Whiskey Project Group has appointed Morgans Financial and Canaccord Genuity as joint lead managers for the IPO.

Elon Musk could more than double his wealth.

Massive SpaceX IPO would make Musk a nearly instant trillionaire

Elon Musk could become the world’s first trillionaire, more than doubling his wealth, if SpaceX goes public next year.

Amart was founded in 1970 by Queensland billionaire John Van Lieshout and now has 66 stores across Australia in large-format sites.

Quadrant presents $1b revenue Amart-Freedom IPO; pitch decks land

Quadrant reckons there’s an opportunity to optimise Freedom’s performance by deploying “the Amart playbook” and co-locating stores.

Elon Musk is aiming for the stars with his latest deal.

Ground control to Elon Musk: SpaceX’s $2.2trn IPO plan is pure AI hype

The planned IPO of SpaceX relies on Elon Musk putting data centres in space. No, seriously.

Sharon AI founder Andrew Leece. The company’s plan is to rent out computing muscle to companies across Asia.

Sharon AI launches $100m capital raising ahead of 2026 IPO

Sharon AI also has terms in place for a debt facility with a large global bank for $US152.4 million ($229 million), bringing the total raise to $US217.4 million.

Amart Furniture and Bunnings at Hoppers Crossing in Victoria.

QPE’s Amart Furniture kicks off early meetings for IPO

Should it succeed, it would join a line-up of listed home retailers including Nick Scali, Adairs, Temple and Webster and Joyce Corporation. 

Barry Regan, chief executive of Saluda Medical, says the company will list on the ASX on Friday.

Saluda Medical shares sink in worst ASX debut in decades

Former Cochlear boss Catherine Livingstone sits on the board of the US-based company which lost more than 50 pct of its value on the first day of trading.

Advertisement
Macquarie’s blown the whistle on passive investing and its impact on the Australian equity market.

Macquarie blows whistle on passive funds, says M&A rules are changing

Index and quant ownership of Australian shares has more than doubled in the past 15 years, bringing unintended consequences.

Sharon AI founder Andrew Leece.

Sharon AI poised to launch $100m pre-IPO round; eyes March IPO

Sharon AI is moving swiftly ahead with its pre-IPO funding round and making a beeline for the ASX in the new year.

Cboe Global Markets has announced the resignation of its CEO Edward Tilly.

Canadian Securities Exchange flags interest in Cboe Australia

CNSX chief Richard Carleton says the Canadian exchange is weighing a bid for Cboe’s exchanges, potentially offering tougher competition for the ASX.

Barry Regan, chief executive of Saluda Medical, says the company will list on the ASX on Friday.

Saluda Medical set for $775m ASX debut

With links to Cochlear, the US-based med-tech company has global ambitions for its spinal cord stimulator technology.

6K Additive boss Frank Roberts, chief financial officer Jonathan Wolak and chairman David Seldin are in Australia to meet institutional investors.

Metal powders manufacturer 6K Additive upsizes IPO

The Pittsburgh-headquartered materials play is set to debut on the ASX with a $267 million market capitalisation.

Original URL: https://www.afr.com/topic/initial-public-offering-1mx1